Ranitidine

1 Drug classified under this active ingredient

H2 Receptor Antagonist. Ranitidine (as HCl) 25 mg/ml, 150 mg / 10 ml.
INJECT: 5 x 2 ml x 50 mg. 50 mg by
slow I.V. inject. or infus. repeated 6-8
hrly. Child: not recommend.
SYR: 300 ml x 150 mg/10 ml. 10 ml 2
x dly. or 20 ml. at bedt. Maint: 10 ml
at bedt.
Duod. ulc., benign gastric ulc., postop.
ulc., GERD, Zollinger-Ellison syndr.